Clinical Trial Update: Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 clinical trial update reports on using filgrastim to treat patients with bortezomib-, carfilzomib-, or IMID-refractory multiple myeloma; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Multiple Myeloma | EARLY_Phase 1 | Status: TERMINATED